Walgreens Chair Pessina to boost stake after Sycamore seals takeover deal, FT reports
Adds details from the report in paragraph 2, 3 and background in paragraph 4
March 18 (Reuters) - Walgreens Boots Alliance's WBA.O executive chair Stefano Pessina will almost double his stake in the U.S. pharmacy group to about 30% as part of its $10 billion takeover by private equity group Sycamore, the Financial Times reported on Tuesday.
Pessina, Walgreens' top shareholder with a roughly 17% stake in the company he helped forge through the 2014 merger of Walgreens and Alliance Boots, will inject cash into it as part of the deal, the FT said, citing people familiar with the matter.
Pessina will also deepen his involvement in the group ahead of a possible break-up, the FT said.
Sycamore is planning a three-way split of Walgreens into a U.S. retail pharmacy, Boots UK and U.S. healthcare, the newspaper had reported in February.
Pessina and Sycamore declined to comment to the FT, while Walgreens did not respond to a request for comment. Reuters could not immediately reach Pessina for comment, while Walgreens and Sycamore did not respond to a request for comment.
(Reporting by Devika Nair in Bengaluru; Editing by Janane Venkatraman and Savio D'Souza)
((Devika.MadhusudhananNair@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
No relevant data is available